• Home
  • About
  • Issues
    • Column 1
      • Energy
      • Healthcare
      • Taxes & Spending
      • Technology
      • Consumer Safety
    • Column 2
      • Agriculture
      • Trade
      • Government Regulation
      • Banking & Investmets
      • Intellectual Property
    • Column 3
      • Property Rights
      • Legal Reform
      • Higher Education
      • Right To Work
      • Retail & Online Commerce
  • Newsroom
  • Contact
info@caseforconsumers.org
Case for ConsumersCase for Consumers
Case for ConsumersCase for Consumers
  • Home
  • About
  • Issues
    • Column 1
      • Energy
      • Healthcare
      • Taxes & Spending
      • Technology
      • Consumer Safety
    • Column 2
      • Agriculture
      • Trade
      • Government Regulation
      • Banking & Investmets
      • Intellectual Property
    • Column 3
      • Property Rights
      • Legal Reform
      • Higher Education
      • Right To Work
      • Retail & Online Commerce
  • Newsroom
  • Contact

CASE Op-Ed in the Washington Times: GOP Voters Want Free-Market Policies for American Biotech to Beat China’s

CASE Op-Ed in the Washington Times: GOP Voters Want Free-Market Policies for American Biotech to Beat China’s

CASE Op-Ed in the Washington Times: GOP Voters Want Free-Market Policies for American Biotech to Beat China’s

July 5, 2023 Healthcare

 

July 5, 2023

Over the last few years, in the face of withering attacks from the left and increasing government controls on our health care system, Republicans have put less emphasis on the importance of a strong U.S. biotech sector.

But as China works to aggressively expand its medical industry and increase America’s dependence on China‘s biotech sector, conservatives can’t afford to lose sight of the critical role that homegrown innovation and free-market dynamics can play in keeping America safe, strong and prosperous.

That’s why Consumer Action for a Strong Economy — an advocacy group I co-founded to fight for American consumers through free-market policies — conducted a national survey this past month of likely voters including Republicans and Republican-leaning independents to understand how they view this evolving landscape. We found that Republican voters have awakened to this reality.

The poll presented these voters with 11 factual arguments in favor of free-market biotech policies to reduce red tape, reform the tax code, and protect intellectual property rights. Our research found that — despite the new populist conventional wisdom on the right — overwhelming majorities of right-leaning voters affirmed that these policies were necessary to keep us secure against the threat from China and create American jobs.

Over 80% of these voters supported these policies to bolster American biotech manufacturing, end dependence on China, and account for the enormous harm China’s intellectual property theft inflicts upon U.S. biotech companies and our economic future. Meanwhile, around three-quarters agree with a free-market approach to protect against unsafe Chinese counterfeit drugs and to make sure the United States remains the leader in biotech innovation.

Read full article here:

Tags: biotechChinaRepublicanssurvey
Share
0

You also might be interested in

CASE Op-Ed – Inside Sources: Report on Corrupt Global Sugar Market Highlights Pathway to Free Trade
sugar in burlap sack with wooden scoop isolated on white background. Full bag of sugar crystals closeup. Sugar

CASE Op-Ed – Inside Sources: Report on Corrupt Global Sugar Market Highlights Pathway to Free Trade

Jun 13, 2019

  Gerard Scimeca – Chairman, CASE June 13, 2019 As[...]

CASE Op-Ed in DC Journal: Trump Has Fewer Than 30 Days to Keep Promise on Flavored Vapes

CASE Op-Ed in DC Journal: Trump Has Fewer Than 30 Days to Keep Promise on Flavored Vapes

Mar 27, 2025

  President Trump rescinded his predecessor’s proposed ban on menthol[...]

CASE Op-Ed – Morning Consult: Innovation Economy Benefits from Merger of Raytheon and United Technologies

CASE Op-Ed – Morning Consult: Innovation Economy Benefits from Merger of Raytheon and United Technologies

Dec 18, 2019

  December 18, 2019 The government’s current review of the[...]

Search

Categories

  • Aegis
  • Agriculture
  • Commerce
  • Communications
  • Consumer Safety
  • Crime
  • Data Privacy
  • Economy
  • Education
  • Energy
  • Entertainment
  • Environment
  • Financial Services
  • Fiscal Policy
  • Healthcare
  • Higher Ed on the Hill
  • Housing
  • Intellectual Property
  • Kentucky
  • Labor
  • Legal
  • Lifestyle
  • Manufacturing
  • Media
  • Regulation
  • Retail
  • Robotexts
  • Taxes
  • TCPA
  • Technology
  • Ticketmaster
  • Trade
  • Transportation
  • Uncategorized
  • Veterans

Archives

Contact Us

CASE Follow

Consumer Action for a Strong Economy - the Free Market Voice for America's Consumers; likes=bookmarks

CASE_forAmerica
case_foramerica CASE @case_foramerica ·
23 Oct

.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.

Reply on Twitter 1849183731690409996 Retweet on Twitter 1849183731690409996 5 Like on Twitter 1849183731690409996 4 Twitter 1849183731690409996
Retweet on Twitter CASE Retweeted
case_foramerica CASE @case_foramerica ·
23 Oct

Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.

By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!

Reply on Twitter 1849132991164874848 Retweet on Twitter 1849132991164874848 6 Like on Twitter 1849132991164874848 2 Twitter 1849132991164874848
Retweet on Twitter CASE Retweeted
case_foramerica CASE @case_foramerica ·
21 Oct

CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/

Reply on Twitter 1848386046033010802 Retweet on Twitter 1848386046033010802 4 Like on Twitter 1848386046033010802 2 Twitter 1848386046033010802
case_foramerica CASE @case_foramerica ·
23 Oct

Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.

By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!

Reply on Twitter 1849132991164874848 Retweet on Twitter 1849132991164874848 6 Like on Twitter 1849132991164874848 2 Twitter 1849132991164874848
Load More

Contact us for more information!

Send us an email so that we can get back to you, as soon as possible.

Send Message
Find out more about consumer issues View Issues

Find us here

  • Case for Consumers
  • 1800 Diagonal Road, Suite 600 Alexandria, VA 22314
  • 703-718-5011
  • info@caseforconsumers.org
  • caseforconsumers.org

Fresh from our blog

  • Nuclear Energy Victory: Trump and Republicans Secure America’s Energy Future
  • Rail Labor is No Friend of the Trump Innovation Agenda
  • CASE Op-Ed in DC Journal: Crime is Driving Inflation: Why Congress Must Act on Cargo Theft
  • Don’t Put Opportunity Zones on the Investment Sidelines

© 2025 · Case for Consumers

  • Home
  • About
  • Issues
  • Contact
  • Privacy policy
  • Terms & Condition
Prev Next